Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Payables (2020 - 2024)

Historic Payables for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $8819.7 billion.

  • Universe Pharmaceuticals' Payables rose 5058.73% to $8819.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8819.7 billion, marking a year-over-year increase of 5058.73%. This contributed to the annual value of $8819.7 billion for FY2025, which is 5058.73% up from last year.
  • According to the latest figures from Q3 2025, Universe Pharmaceuticals' Payables is $8819.7 billion, which was up 5058.73% from $5856.8 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Payables peaked at $8819.7 billion during Q3 2025, and registered a low of $4.1 million during Q1 2023.
  • For the 5-year period, Universe Pharmaceuticals' Payables averaged around $1834.8 billion, with its median value being $8.3 million (2021).
  • Its Payables has fluctuated over the past 5 years, first crashed by 9999.96% in 2021, then skyrocketed by 35552673.36% in 2024.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Payables stood at $9.6 million in 2021, then decreased by 27.3% to $7.0 million in 2022, then surged by 23388.42% to $1.6 billion in 2023, then surged by 355526.73% to $5856.8 billion in 2024, then skyrocketed by 50.59% to $8819.7 billion in 2025.
  • Its Payables was $8819.7 billion in Q3 2025, compared to $5856.8 billion in Q3 2024 and $4.4 million in Q1 2024.